TNF and hematologic disorder: In the current study, we aimed to characterize the cellular and humoral immune profile in immunocompromised patients including solid organ transplant (SOT) patients on calcineurin inhibitor tacrolimus, hematological malignancies, patients receiving B-cell-depleting medication (anti-CD20) and TNF-α inhibitors.